The presence of methylation on the promoter region of four genes in particular (p16INK4a, CDH13, RASSF1 and APC) in patients with early stage NSCLC that was treated by means of surgery has been associated with early recurrence [187]. Here, CDKN2A is linked to non-small cell lung carcinoma.